John Sharman - May 1, 2024 Form 4 Insider Report for UNIVERSAL BIOSENSORS INC (UBI)

Role
Chief Executive Officer
Signature
/s/ John Sharman
Stock symbol
UBI
Transactions as of
May 1, 2024
Transactions value $
$9,458
Form type
4
Date filed
5/3/2024, 06:23 AM
Previous filing
Mar 25, 2024
Next filing
May 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UBI Common Stock Award $1.5K +10K +0.78% $0.15* 1.29M May 1, 2024 By wife F1, F2
transaction UBI Common Stock Award $3.46K +23.1K +28.82% $0.15* 103K May 1, 2024 Direct F2
transaction UBI Common Stock Award $4.5K +30K +8.23% $0.15* 395K May 1, 2024 By superannuation fund F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding UBI Performance Rights 2.5M May 1, 2024 Common Stock 2.5M Direct F4
holding UBI Performance Rights 1.25M May 1, 2024 Common Stock 1.25M Direct F5
holding UBI Stock Option (Right to Buy) 2.36M May 1, 2024 Common Stock 2.36M $0.25 Direct F2, F6
holding UBI Stock Option (Right to Buy) 1.36M May 1, 2024 Common Stock 1.36M $0.30 Direct F2, F6
holding UBI Stock Option (Right to Buy) 1M May 1, 2024 Common Stock 1M $0.30 By superannuation fund F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of the shares held by his wife except to the extent of his pecuniary interest therein, and this report should not be deemed an admission that the reporting person is the beneficial owner of his wife's shares for purposes of Section 16 or for any other purpose.
F2 The price reported is stated in Australian dollars.
F3 The reporting person disclaims beneficial ownership of the shares held by his superannuation except to the extent of his pecuniary interest therein, and this report should not be deemed an admission that the reporting person is the beneficial owner of his superannuation funds shares for purposes of Section 16 or for any other purpose.
F4 Each performance right represents a contingent right to receive one share of common stock of Universal Biosensors, Inc. ("UBI"). The performance rights vest upon, among other triggers, UBI's market capitalization having achieved a specified threshold.
F5 Each performance right represents a contingent right to receive one share of common stock of UBI. The performance rights vest upon a change of control transaction with a value greater a specified threshold.
F6 These options are fully vested and became exercisable after September 24, 2020.